-
Rotateq targets five major strains of rotavirus, which account for 90% of rotavirus disease.
BBC: NEWS | Health | Diarrhoea vaccine tests 'hopeful'
-
But now, given their action, the finding of virus DNA in Rotateq and the inevitable hysteria of the vaccine activists, some parents will be confused enough to delay vaccinating their children.
FORBES: Magazine Article
-
The first study - involving more than 68, 000 infants aged six to 12 weeks - found a vaccine called Rotateq being developed by the pharmaceutical company Merck could safely prevent 98% of severe cases of viral diarrhoea and vomiting.
BBC: NEWS | Health | Diarrhoea vaccine tests 'hopeful'
-
Do they extend it to Rotateq?
FORBES: Magazine Article
-
The FDA thought it could get away with its action because, well, it thinks it can get away with anything these days. (Its Obama-appointed General Counsel has as much as said so.) And regulators knew that there was an alternative vaccine available, Rotateq, produced by Merck.
FORBES: Magazine Article